The Patent Finder

Servier Pharmaceuticals LLC

72 patents currently held · Updated Nov 22, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Jun 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 6, 2026
    The maintenance fee for Therapeutically Active Compounds and Their Methods of Use (US 11,667,673) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
  • 1 fee due Feb 8, 2027
    The maintenance fee for Methods of use for trisubstituted benzotriazole derivatives (US 11,717,512) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
  • 2 fees due Apr 8 to 22, 2027 · next Apr 8
  • 2 fees due Jun 19 to 26, 2027 · next Jun 19
  • 1 fee due Jul 9, 2027
    The maintenance fee for Therapeutically active compounds and their methods of use (US 11,865,079) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
  • 1 fee due Oct 7, 2027
    The maintenance fee for Methods and compositions for cell-proliferation-related disorders (US 10,610,125) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
  • 2 fees due Nov 5 to 19, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 24, 2026
  • 1 term has ended since Aug 24, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,610,125Methods and compositions for cell-proliferation-related disorders
In force
 · USPTO record
In forceUSPTO record
US 8,883,438Method for Diagnosing Cell Proliferation Disorders Having a Neoactive Mutation at Residue 97 of Isocitrate Dehydrogenase 1
In force
 · Medium confidence
In forceMedium confidence
US 9,982,309Method for Treating Cell Proliferation Related Disorders
In force
 · Medium confidence
In forceMedium confidence
US 10,711,314Methods for Diagnosing Idh-Mutant Cell Proliferation Disorders
In force
 · Medium confidence
In forceMedium confidence
US 9,434,979Methods and compositions for cell-proliferation-related disorders
In force
 · USPTO record
In forceUSPTO record
US 9,512,107Therapeutically Active Compositions and Their Methods of Use
In force
 · High confidence
In forceHigh confidence
US 9,656,999Therapeutically Active Compounds and Their Methods of Use
In force
 · High confidence
In forceHigh confidence
US 10,294,215Therapeutically Active Compounds and Their Methods of Use
In force
 · Low confidence
In forceLow confidence
US 9,850,277Therapeutically Active Compositions and Their Methods of Use
In force
 · High confidence
In forceHigh confidence
US 10,640,534Therapeutically Active Compositions and Their Methods of Use
In force
 · High confidence
In forceHigh confidence
10 of 72 patents shown.
Pro members see all 72.
Pro members: see all 72 patents
Also on record, not counted in the 72: 1 patent in force now held by others · 14 lapsed for an unpaid fee · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 3 abandoned · 9 no status recorded

Rows 11 to 18 of 18 are for members. The first 10 are on the company page.
Pro members see all 18 published applications.
Upgrade to Pro
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited